Apoptosis (15)
apoptosis (7)
Breast cancer (7)
Photodynamic therapy (7)
Inflammation (5)
Triple negative breast cancer (4)
Drug delivery system (3)
Gastric ulcer (3)
triple-negative breast cancer (3)
ZIF-8 (3)
5-Aminolevulinic acid (2)
Abemaciclib (2)
ATR (2)
Cabazitaxel (2)
Canine mammary gland tumor (2)
DNA damage response (2)
Drug delivery (2)
Gallic acid (2)
Gemcitabine (2)
gene expression (2)
indoximod (2)
Oxidant damage (2)
Talazoparib (2)
Tight junctions (2)
Triple-negative breast cancer (2)
Ulcerative colitis (2)
Vanillic acid (2)
Xenin-25 (2)
Zinc (2)
Zinc picolinate (2)
3-dioxygenase (IDO) (1)
5-ALA (1)
5-ALA | Apoptosis | Cisplatin | Photodynamic therapy | Triple negative breast cancer (1)
5-aminolaevulinic acid (1)
5-Aminolevulic acid (5-ALA) (1)
5-Aminolevulic acid (5-ALA) | Apoptosis | Hepatocellular carcinoma | Photodynamic therapy (1)
5-aminolevulinic acid (1)
5-Aminolevulinic acid | Apoptosis | Canine mammary gland tumor | Photodynamic therapy (1)
5-Aminolevulinic acid | Apoptosis | Canine mammary tumors | Photodynamic therapy (1)
5-Fluorouracil (1)
5-FU (1)
5-Sulfosalicylic acid (1)
6 inhibitors (1)
abemaciclib (1)
Abemaciclib | Apoptosis | Resistance | Talazoparib | Triple-negative breast cancer (1)
AKT (1)
aminocarbasugars (1)
aminocarbasugars | aminocyclitols | cell line | enzyme inhibition (1)
aminocyclitols (1)
antibacterial efficacy (1)
antibacterial efficacy | endodontic disinfection | hypochlorous acid | irrigation solutions | silver nanoparticles (1)
antibacterial properties (1)
Antibiofilm activity (1)
Anticancer effect (1)
Anticancer effect | Apoptosis | Breast cancer | Genistein | TLR3 (1)
anti-freezing (1)
anti-freezing | antibacterial properties | drug release | hydrogel | self-healing | tannic acid (1)
Apoptosis | Cabazitaxel | Taxanes | Toll like receptor 3 | Toll like receptors (1)
apoptosis | canine mammary gland tumour | histone deacetylase inhibitor | sodium butyrate (1)
Apoptosis | Coelomic fluid | Eisenia foetida | Prostate Cancer (1)
apoptosis | dog | molecular classification | PI3K/Akt/mTOR signalling pathway | tyrosin kinase inhibitors (1)
Apoptosis | Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) | Talazoparib | TLR3 | TLR9 | Toll-like receptors (TLRs) (1)
ATR inhibitors (1)
atypical cell death (1)
Au (1)
Automated experiment (1)
B activity (1)
bee venom (1)
Bioactivity (1)
Boswellic acid (1)
Box-Behnken Design (1)
Brain-derived neurotrophic factor (BDNF) (1)
breast cancer (1)
Breast Cancer | Epidermal Mesenchymal Transition | IL-6 | Tamoxifen (1)
Breast cancer | Exosomes | PI3K/AKT/mTOR signaling | Receptor tyrosine kinases (1)
Breast cancer | Inflammation | NCB-0846 | TNIK (1)
c.1103A > G (1)
cabazitaxel (1)
caffeic acid (1)
caffeic acid (CA) (1)
cancer (1)
Cancer Therapy (1)
canine mammary gland tumour (1)
Canine mammary tumors (1)
Carcinoma (1)
Carcinosarcoma (1)
Castration resistant metastatic prostate cancer (1)
CDK4 (1)
CDK4/6 inhibitors (1)
cell cycle (1)
Cell cycle (1)
cell line (1)
cells (1)
characterization (1)
CHEK2 gene (1)
Chitosan hydrogels (1)
Cisplatin (1)
Coelomic fluid (1)
Colorectal cancer (1)
combination therapy (1)
Combination therapy (1)
combination therapy | diabetes mellitus | metformin | testis | vitamin C (1)
Combined therapy (1)
complete response (1)
Confocal Microscopy (1)
contrast media (1)
contrast media | contrast-induced nephropathy | inflammation | kidney injury | reactive oxygen species (1)
contrast-induced nephropathy (1)
Curcumin (1)
DFT (1)
DHEA-induced PCOS (1)
diabetes mellitus (1)
Docking (1)
dog (1)
dopamine transporter (1)
dopamine transporter | gene expression | methamphetamine | psychic experiences | vesicular monoamine transporter (1)
Dosage control (1)
Dosimetry (1)
drug delivery systems (1)
Drug Delivery Systems (1)
drug release (1)
Drug resistance (1)
Early-onset breast cancer (1)
Eisenia foetida (1)
Embedded systems (1)
endodontic disinfection (1)
enzyme inhibition (1)
Epacadostat (1)
epithelial-mesenchymal transition (1)
Exosomes (1)
Fatty acid profile (1)
Feline mammary gland tumor (1)
Fluorescent (1)
gene expression | IL-6 | neoadjuvant chemotherapy | prognostic markers | STAT3 | triple-negative breast cancer (1)
Genistein (1)
Glioblastoma (1)
Glucose oxidase (1)
granulosa cell proliferation (1)
hepatitis B (1)
hepatitis B | hepatitis B vaccine response | metabolic dysfunction-associated steatotic liver disease | miRNA (1)
Hepatitis B | NF‑kB | pro-inflammatory cytokines | systemic inflammation | vaccine response (1)
hepatitis B vaccine response (1)
Hepatitis B virus | immune response | inflammatory parameters | systemic inflammation | vaccine response (1)
Hepatocellular carcinoma (1)
histone deacetylase inhibitor (1)
honey bee (1)
hydrogel (1)
hypochlorous acid (1)
IL-6 (1)
indoleamine 2 (1)
indoleamine 2,3-dioxygenase (1)
indoleamine 2,3-dioxygenase inhibitors (1)
indoximod | MDSCs | melatonin | TNBC (1)
inflammation (1)
inhibitors (1)
irrigation solutions (1)
kidney injury (1)
Lauric acid (1)
Lenalidomide-like novel drug derivative (1)
Light-emitting diodes (LEDs) (1)
Lipid hydrolysis (1)
Liver metastasis (1)
Maternal separation (1)
MCF-7 cells (1)
MCF-7 cytotoxicity (1)
MDSCs (1)
Meclofenamic acid (MA) (1)
melatonin (1)
metabolic dysfunction-associated steatotic liver disease (1)
Metastatic castration-resistant prostate cancer (1)
metformin (1)
methamphetamine (1)
MIL-100 (1)
MIL-100 (Fe) (1)
microRNA (1)
MiR-135b (1)
MiR-99b (1)
miRNA (1)
MiRNA (1)
MiRNA | Surgical treatment | Thyroid cancer (1)
MMPs (1)
molecular classification (1)
mTOR signaling (1)
Multidrug resistance (1)
Multiple real samples (1)
Nano-antibiotic (1)
neoadjuvant chemotherapy (1)
NF-κ (1)
Non-thermal processing (1)
ovarian folliculogenesis (1)
Oxidative damage (1)
Oxidative stability (1)
PARP inhibitor resistance (1)
PARP inhibitors (1)
PCOS (1)
Peritonitis carcinomatosis (1)
phoenixin-14 (1)
Phosphatidylinositol 3-kinase (PI3K) (1)
PI3K (1)
PI3K/Akt/mTOR signalling pathway (1)
Poly (ADP -ribose) polymerase (PARP) (1)
prognostic markers (1)
pro-inflammatory cytokines (1)
prostate cancer (1)
Prostate Cancer (1)
psychic experiences (1)
Quercetin (1)
radiotherapy (1)
reactive oxygen species (1)
Receptor tyrosine kinases (1)
Resistance (1)
rutaecarpine (1)
self-healing (1)
silver nanoparticles (1)
Silver nanoparticles (1)
SLNs (1)
Small cell lung carcinoma (SCLC) (1)
snail (1)
sodium butyrate (1)
Solid lipid nanoparticles (1)
solid lipid nanoparticles (SLNs). (1)
STAT3 (1)
Stress (1)
subtype (1)
Surgical treatment (1)
Synergism (1)
tannic acid (1)
Taxanes (1)
TEM (1)
testis (1)
Thermal processing (1)
Thiazolidine-4-one (1)
Thyroid cancer (1)
TIMPs (1)
TLR3 (1)
TNBC (1)
toll-like receptor 4 (1)
Topotecan (TPT) (1)
Treadmill exercise (1)
triple negative breast cancer (1)
triple negative breast cancer (TNBC) (1)
Triple negative breast cancer cells (1)
tumor necrosis factor-alpha (1)
tyrosin kinase inhibitors (1)
Vagal afferent denervation (1)
Vagal afferent fibers (1)
Variant of uncertain significance (1)
vesicular monoamine transporter (1)
vitamin C (1)
